Assists in the design, deployment, and ongoing implementation of innovative care delivery models for life sciences, healthcare, and informatics clients
Regularly advises companies pivoting to healthcare vertical offerings based on legacy technology and strategic assets
Advises clients on AI governance, public trust, and AI deployment
Advises clients on HIE participation, data sharing and compliance
Counsels clients on the development of data and biospecimen registries, real-world evidence platforms, and biobanking programs
Jennifer S. Geetter focuses her practice on the development, delivery, and implementation of digital health and artificial intelligence (AI) solutions, data, and research. She works closely with both adopters and developers to bring innovation in healthcare diagnosis, treatment and delivery to patients and providers, offering guidance on patient onboarding, provider implementation, privacy, and regulatory issues. She advises global life sciences, healthcare, and informatics clients on legal issues related to digital health, biomedical innovation, research compliance, global privacy and data security laws, and financial relationship management.
See more
- Assisted an informatics company with interoperability, privacy, data strategies, and related considerations
- Assisted a retail client in launching a new health vertical built on the backbone of legacy technology and expertise
- Assisted a client in responding to the unauthorized disclosure of company records to public-facing AI engines
- Provided comprehensive advice on the delivery of virtual health solutions to support and expand primary care
- Assisted in the development and deployment of network research arrangements
- The Best Lawyers in America, Healthcare Law, 2022-2027
- Chambers USA, Healthcare, 2020-2026
- District of Columbia Courts, Capital Pro Bono High Honor Roll, 2023
- Human Rights First, board of directors
- Ohev Sholom Congregation, board of directors
- Harvard Law School, JD, cum laude
- Columbia College, BA, magna cum laude
- District of Columbia
- Massachusetts
- New York
- English

Emmanuelle Trombe
Emmanuelle Trombe is the co-head of the Firm’s Life Sciences industry practice. She represents pharmaceutical, medical device and bio-pharmaceutical companies globally in transactional matters in relation to M&A and divestitures, joint ventures and strategic partnerships, large-scale projects, outsourcing projects, product development, licensing agreements and regulatory matters. She also advises venture capital funds and bio-pharmaceutical companies in connection with a broad range of financing activities. As well as co-heading the Firm’s Life Sciences Group, Emmanuelle serves as an elected member of the Firm’s Management Committee.
Emmanuelle is distinguished in Chambers Europe and Legal 500 EMEA in life sciences transactions, where she is highly recommended for her experience in the pharmaceutical, healthcare, biotech and medical devices industries and described as very responsive, smart, flexible and business-minded. She has been distinguished as the Lawyer of the Year in Life Sciences for 2024.
- Advised Orano Med its in collaboration with Molecular Partners to co-develop novel Radio-DARPin therapeutics (RDTs) that use Orano Med’s 212Pb radioisotope as a payload to selectively kill cancer cells
- Advised Pierre Fabre in the acquisition of Kinnate Biopharma’s investigational pan-RAF inhibitor, Exarafenib, and other pan-RAF program assets
- Advised Owkin on funding to launch Bioptimus, the first universal AI model designed to fuel breakthrough discoveries and accelerate innovation in biomedicine
- Advised Sensorion, a pioneering clinical-stage biotechnology company specializing on the development of new therapies to restore, treat and prevent hearing loss disorders, on its new financing of over EUR 50 million from existing and new investors specializing in the healthcare sector
- Advised Novartis Groupe France SAS in the sale of the company CellforCure and its cell and gene therapy development and production site in Les Ulis, France, to Seqens SAS
- Advised Aqemia, a pioneering pharmatech company leveraging AI and quantum-inspired physics to accelerate the discovery of small molecule drug candidates with higher probability of success in the clinic, in its multi-year research collaboration with Sanofi
- The Legal 500 EMEA, Hall of Fame, France: Healthcare and Life Sciences, 2026
- The Legal 500 EMEA, Leading Individual in France: Healthcare and Life Sciences, 2022-2025
- Chambers France, Band 1 in Pharma/Life Sciences: Corporate, 2026
- Best Lawyers in France,, Corporate Law & Biotechnology and Life Sciences, 2012-2026
- Chambers Europe, , Band 1 in France: Pharma/Life Sciences, 2014-2024
- Médecins sans Frontières, regularly provides contractual advice to this international humanitarian medical association
- ESCP Business School
- Paris-Panthéon-Assas University, LLM, Tax and Commercial Law
- Complutense University of Madrid, Master’s, AMSEC
- Paris
- English
- French
- Spanish
- Italian

Sabine Naugès
Sabine Naugès counsels clients on all aspects of public law, including administrative and regulatory, competition and constitutional law. Among other high-profile clients, Sabine has advised telecommunications companies France Télécom and Orange on regulatory matters in cases before administrative and commercial courts, and before EU and French competition authorities. She also regularly represents major companies with interests in a wide range of industries, including aerospace, energy, oil and gas, and public health care, before the French government and in litigation, in a range of regulatory and administrative matters.
- Advised a French multinational telecommunications company on regulatory projects relating to the development and access to the fiber optic network and in connection with the renewal of their mobile license, as well as in connection with several disputes before the European Commission concerning state aid
- Advised one of the largest independent oil companies in Europe in an International Centre for Settlement of Investment Disputes (CIRDI) arbitration against the Tunisian government relating to an offshore oil concession and also in an arbitration case against the French government
- The Legal 500 EMEA, Recommended, 2022-2026
- Chambers France, Band 4 in Public Law, 2026
- The Best Lawyers in France, 2025 & 2026
- Chambers Europe, France: Public Law, 2022-2024
- Euromoney, EMEA Women in Business Law, International Trade Lawyer of the Year, 2023
- Paris 1 Panthéon-Sorbonne University, Master’s, Public Law
- Paris 1 Panthéon-Sorbonne University, Master’s Degree (DEA), Public Law
- Paris 1 Panthéon-Sorbonne University, PhD, Public Law
- American University Washington College of Law, LLM, Law and Government
- New York
- Paris
- English
- French

Anne-France Moreau
Anne-France Moreau has over a decade of experience counselling clients on corporate and general commercial law, with a particular focus on pharmaceutical, medical device, health care and cosmetics industries. Anne-France assists French and non-French groups in the preparation and negotiation of collaborations, licenses and distribution agreements. She has experience on a number of merger, acquisition and private equity transactions, including divestitures, financing rounds and joint ventures for French and non-French corporations. Further, Anne-France regularly handles digital health matters as well as regulatory issues.
Anne-France worked in a legal department of a French major leading pharmaceutical company, where she gained experience in pharmaceutical operations.
- Advised Egle Therapeutics in a corporate strategic research alliance with Takeda Pharmaceutical Company Limited to uncover novel tumor specific regulatory T-cell Targets and develop unique Anti-Suppressor-Based Immunotherapy
- Advised vaccines pioneers Themis on landmark sale to Merck
- Advised Innate Pharma in its multi-term collaboration with AstraZeneca
- Chambers France, Band 3 in Pharma/Life Sciences: Corporate, 2026
- The Legal 500 EMEA, Recommended, 2019-2026
- Who’s Who Legal: France 2024
- Chambers Europe, France: Pharma/Life Sciences: Corporate, 2024
- The Best Lawyers in France, Healthcare Law, 2025 & 2026
- University of Paris I Panthéon-Sorbonne, Licence in Private Law
- University of Paris I Panthéon-Sorbonne, Master’s 1, Business Law
- University of Paris V Descartes, Master’s 2, Business and European Law
- Paris
- French
- English

Charlotte Michellet
Charlotte Michellet focuses her practice on public, administrative and regulatory law.
Prior to joining the Firm, Charlotte spent almost three years as a jurist in the legal department of the Conseil Supérieur de l’Audiovisuel (French Audiovisual Council) in charge of the regulation of national TV and interned at a prestigious French law firm. She also worked for two years assisting judges at the Conseil d’État, the French Administrative Supreme Court.
- The Legal 500 EMEA, Recommended, 2022-2026
- The Best Lawyers in France, “Ones to Watch” in Administrative & Public Law, 2024-2026
- Sciences Po Paris, Master''s, Master’s 2
- Paris 1 Panthéon-Sorbonne University, Master’s 2, Public Business Law
- Paris
- English
- French

Aroma Sharma
Aroma Sharma focuses her practice on a wide range of corporate and transactional matters, acting predominantly for private and emerging companies. Aroma has advised clients on mergers and acquisitions, debt and equity financing, corporate and equity restructuring and recapitalizations and joint ventures in various industries, including technology and health and life sciences. She also advises clients regularly on general corporate and corporate governance matters. Aroma also has experience working on cross-border transactions, including business’ international expansion into new territories.
- Best Lawyers: Ones to Watch in America, Corporate Law and Mergers and Acquisitions Law, 2021-2025
- South Asian Bar Association of Northern California, former president
- Asian Pacific American Bar Association, member
- Leading Women in Technology, WILpower™ 2017 Incubator Program, alumnus
- Santa Clara University School of Law, JD, High Technology Certificate
- University of California, Berkeley, BA
- California
- English
- Hindi
- Punjabi
Bhanu K. Sadasivan, PhD
Bhanu Sadasivan focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.
- Representing Alnylam in litigation over patents covering lipids and lipid nanoparticles
- Representing Natera in litigation over patents covering methods of preparing DNA
- Represented Quidel in a patent litigation over lateral flow assay method
- Represented Amgen in a patent litigation matter over novel antibody therapeutics for the treatment of high LDL-cholesterol (Amgen v. Sanofi, et al., (D. Delaware))
- Represented Ambry Genetics in an IPR proceeding that resulted in institution of two of the petitions before favorable settlement
- Lawdragon, Top 500 Leading Litigators in America, 2022-2026
- Best Lawyers in America, Litigation – Patent, 2024-2027; Litigation – Intellectual Property, 2025-2026
- Managing Intellectual Property, IP Stars, Patent Star, 2021-2026
- IAM Patent 1000, The World’s Leading Patent Practitioners, 2022-2025
- Legal 500 US, Recommended, 2021, 2022 and 2024
- Super Lawyers, 2024-2025; Rising Star, IP litigation, 2013-2014
- Asian Law Alliance, board member and previous board president
- University of California, Berkeley School of Law, JD
- Yale University, PhD, Immunology
- All India Institute of Medical Sciences, MS, Immunology, with honors
- All India Institute of Medical Sciences, BSc, Human Biology, with honors
- California
- US Court of Appeals for the Federal Circuit
- US Court of Appeals for the Ninth Circuit
- US District Court for the Central District of California
- US District Court for the Northern District of California
- US Patent and Trademark Office
- English
- Tamil

Judy Mohr, PhD
Judy Mohr, PhD, helps companies maximize product protection and intellectual property (IP) value by focusing on the business goals of the company and designing a patent portfolio to meet those objectives. Her practice encompasses US and non-US patent procurement, post-grant proceedings (including reexamination and inter partes review), IP due diligence on the investor side and the company side, negotiation of agreements, and development of IP strategies. She assists companies in the pharmaceutical, medical diagnostics, medical device, and gas and liquid separations industries.
- Led IP diligences for a diagnostic testing company in several acquisitions of complementary businesses.
- Manages the patent portfolio for Quidel Corporation (NASDAQ: QDEL), a medical manufacturing and diagnostic testing company, as well as assisting in diligence for corporate transactions
- Provides strategic patent advice and handles patent matters for Corium (NASDAQ: CORI), a leader in design and manufacture of polymer film products for drug delivery
- Serves as IP Counsel to Heron Therapeutics, Inc. to manage its patent portfolio and advise on patent-related regulatory matters
- Serves as IP Counsel to advise on patent strategy and handle patent application preparation and worldwide filings for many start-up companies, including KAI Pharmaceuticals (acquired by AMGEN), Hallux Inc., and Delpor
- LMG Life Sciences, Leading Life Sciences Lawyer, 2021-2022
- Best Lawyers in America, Biotechnology and Life Sciences Practice (2023-2024 and 2026), Litigation – Intellectual Property, 2025-2026
- Legal 500 US, 2021 and 2023-2025
- Chambers USA
- IAM Patent 1000 – The World’s Leading Patent Practitioners, 2014-2025
- Former Advisory Board Member and Lecturer, Center for Innovation & Entrepreneurship, Santa Clara University
- Program Lecturer, SPARK, Stanford University
- Santa Clara University School of Law, JD, Order of the Coif
- The University of Texas at Austin, PhD, Chemical Engineering
- Pepperdine University, BS, Biology, summa cum laude
- California
- US Patent and Trademark Office
- English

Julie Miraglia Kwon
Julie Miraglia Kwon advises wealthy individuals, families, closely held businesses, charities and corporate fiduciaries on all aspects of estate, gift and generation-skipping transfer tax planning, trust and estate administration, business succession, charitable planning and governance, and contested trust and tax matters.
- Best Lawyers in America, Trusts and Estates, 2019-2027
- Best Lawyers in America, Lawyer of the Year in San Jose: Trusts and Estates, 2022, 2025 and 2027
- Chambers High Net Worth, Band 1 in California: Northern: Private Wealth Law and Nationwide: Private Wealth Law: Western Region, 2016-2026
- Chambers USA 2011–2016, Wealth Management*
- Legal 500 US Private Client, Leading Partner in California: Private Wealth, 2026
- American College of Trust & Estate Counsel, fellow
- American Bar Association, Real Property, Trust & Estate Section: Supervisory Council member (2012-2017); chair of the Income & Transfer Tax Planning Group (2011-2012); chair of the Estate & Gift Tax Committee (2007-2008); co-chair of the GST Tax Committee (2005-2006); co-founder and co-chair of the Young Lawyers Network (2007)
- Silicon Valley Community Foundation, chair of the Professional Advisory Council; former board member (2015-2022)
- State Bar of California, Trust & Estates Section, Executive Committee member 2011–2017
- American Law Institute, Estate Planning Advisory Panel member
- Yale Law School, JD
- Stanford University, BA, with distinction
- California
- Illinois
- US Tax Court
- English

Laurelle M. Gutierrez
Laurelle M. Gutierrez has a diverse practice representing high-net-worth individuals and their families with respect to all aspects of gift, estate and generation-skipping wealth-transfer tax planning, as well as trust and estate administration.
- Designing multigenerational and multinational plans for high-net-worth individuals and families to foster family harmony while minimizing the effect of estate, gift and generation-skipping transfer taxes
- Advising fiduciaries in complex trust and probate administrations
- American Jurisprudence Award for Legal Research and Writing
- Best Lawyers in America, Trust and Estates, 2013-2027
- Chambers High Net Worth, California: Northern: Private Wealth Law, 2016-2026
- Private Client Global Elite, 2018–2021, Legal Week
- Super Lawyers, Northern California, 2008–2021
- State Bar of California, Tax Section, Executive Committee
- San Mateo County Health Foundation, former board member and past chair
- Society of Trust and Estate Professionals
- University of San Francisco School of Law, JD
- University of California, Berkeley, BA
- California
- US District Court for the Northern District of California
